Acutaas Chemicals Intrinsic Value

ACUTAAS • Healthcare

Acutaas Chemicals (ACUTAAS) median intrinsic value is ₹740.34 from 9 valuation models (range ₹644–₹1234), vs current price ₹2467.80 — -70.0% downside (Trading Above Calculated Value), margin of safety -100.0%. For current market price and key ratios, visit ACUTAAS share price.

Current Stock Price
₹2467.80
Primary Intrinsic Value
₹776.16
Market Cap
₹101.2K Cr
-70.0% Downside
Median Value
₹740.34
Value Range
₹644 - ₹1234
Assessment
Trading Above Calculated Value
Safety Margin
-100.0%

ACUTAAS Valuation Methods Summary — DCF, Graham Number & P/E

Acutaas Chemicals intrinsic value across 9 models vs current price ₹2467.80 — upside/downside and value range per method. Browse ACUTAAS balance sheet details for revenue, profit, balance sheet and cash flow data.

Method Type Intrinsic Value Range Upside/Downside Details
P/E Based Valuation earnings ₹776.16 ₹620.93 - ₹931.39 -68.5% EPS: ₹35.28, Sector P/E: 22x
Book Value Method asset ₹643.90 ₹579.51 - ₹708.29 -73.9% Book Value/Share: ₹321.95, P/B: 2.0x
Revenue Multiple Method revenue ₹740.34 ₹666.31 - ₹814.37 -70.0% Revenue/Share: ₹308.29, P/S: 2.0x
EBITDA Multiple Method earnings ₹1024.39 ₹921.95 - ₹1126.83 -58.5% EBITDA: ₹420.00Cr, EV/EBITDA: 10x
Simple DCF (5Y) dcf ₹987.12 ₹789.70 - ₹1184.54 -60.0% CF Growth: 15.0%, Discount: 15%
PEG Ratio Method growth ₹740.34 ₹666.31 - ₹814.37 -70.0% EPS Growth: 8.0%, Fair P/E: 6.4x
Growth Adjusted P/E growth ₹740.34 ₹666.31 - ₹814.37 -70.0% Revenue Growth: 6.0%, Adj P/E: 15.5x
ROE Based Valuation profitability ₹1233.90 ₹1110.51 - ₹1357.29 -50.0% ROE: 21.8%, P/E Multiple: 16x
Graham Defensive Method conservative ₹740.34 ₹666.31 - ₹814.37 -70.0% EPS: ₹35.28, BVPS: ₹321.95
Method Types: Earnings Asset DCF Growth Dividend Conservative

ACUTAAS Intrinsic Value vs Market Price — All Valuation Models

Acutaas Chemicals fair value range ₹644–₹1234 vs current market price ₹2467.80 across 9 valuation models. Compare with ACUTAAS DCF to assess whether the stock is under or overvalued.

ACUTAAS Intrinsic Value Analysis — Undervalued or Overvalued?

Acutaas Chemicals median intrinsic value ₹740.34, current price ₹2467.80 — Trading Above Calculated Value by 70.0%, margin of safety -100.0%.

What is the intrinsic value of ACUTAAS?

Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Acutaas Chemicals (ACUTAAS) is ₹740.34 (median value). With the current market price of ₹2467.80, this represents a -70.0% variance from our estimated fair value.

The valuation range spans from ₹643.90 to ₹1233.90, indicating ₹643.90 - ₹1233.90.

Is ACUTAAS undervalued or overvalued?

Based on our multi-method analysis, Acutaas Chemicals (ACUTAAS) appears to be trading above calculated value by approximately 70.0%.

ACUTAAS Financial Health — Key Ratios vs Industry Benchmarks

Acutaas Chemicals financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Current Ratio 29.33 Industry Standard: 2.0+ Above 2.0 Measures short-term liquidity capacity
Return on Equity 21.8% Industry Standard: 15%+ Above 15% Measures shareholder return efficiency
Operating Margin 31.0% Industry Standard: 20%+ Above 20% Indicates operational efficiency level
Asset Turnover Ratio 0.82x Industry Standard: 1.0x+ Above 0.5x Measures asset utilization efficiency

ACUTAAS Cash Flow Quality — Operating & Free Cash Flow

Acutaas Chemicals operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2025 ₹118 Cr ₹6 Cr Positive Free Cash Flow 7/10
March 2024 ₹125 Cr ₹-58 Cr Positive Operating Cash Flow 6/10
March 2023 ₹66 Cr ₹50 Cr Positive Free Cash Flow 8/10
March 2022 ₹-12 Cr ₹-73 Cr Negative Cash Flow 3/10
March 2021 ₹28 Cr ₹-23 Cr Positive Operating Cash Flow 6/10